Paper38412036
A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope.
Joshi VR and 11 others. J Virol, 2024. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope. Papers, record 38412036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38412036
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Broadly Neutralizing Antibodies | Major topic |
| HIV Infections | Major topic |
| Humans | |
| Amino Acids | |
| CD4 Antigens | |
| env Gene Products, Human Immunodeficiency Virus | |
| Epitopes | |
| HIV Antibodies | |
| HIV Antigens | |
| HIV Envelope Protein gp120 | |
| HIV Seropositivity | |
| HIV-1 | |
| AIDS Vaccines |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI137057 | NIAID NIH HHS | United States | R01AI137057 | PubMed | NIH RePORTER |
| R01 AI153098 | NIAID NIH HHS | United States | R01AI153098 | PubMed | NIH RePORTER |
| R01 AI155447 | NIAID NIH HHS | United States | R01AI155447 | PubMed | NIH RePORTER |
| AI04715 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | PubMed | PubMed | ||
| P01 AI104715 | NIAID NIH HHS | United States | P01AI104715 | PubMed | NIH RePORTER |
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23539181 | Rational HIV immunogen design to target specific germline B cell receptors. | Science | 2013 | https://conductscience.org/library/papers/23539181 | PubMed |
| 2 | 26091035 | Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice. | Cell | 2015 | https://conductscience.org/library/papers/26091035 | PubMed |
| 3 | 26949186 | Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody. | Cell | 2016 | https://conductscience.org/library/papers/26949186 | PubMed |
| 4 | 26702094 | Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26702094 | PubMed |
| 5 | 20439465 | Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20439465 | PubMed |
| 6 | 7973652 | Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. | Science | 1994 | https://conductscience.org/library/papers/7973652 | PubMed |
| 7 | 27013733 | HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. | Science | 2016 | https://conductscience.org/library/papers/27013733 | PubMed |
| 8 | 30936546 | Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. | Nat Med | 2019 | https://conductscience.org/library/papers/30936546 | PubMed |
| 9 | 23524883 | Structural basis for HIV-1 gp120 recognition by a germ-line version of a broadly neutralizing antibody. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23524883 | PubMed |
| 10 | 27192579 | Early Antibody Lineage Diversification and Independent Limb Maturation Lead to Broad HIV-1 Neutralization Targeting the Env High-Mannose Patch. | Immunity | 2016 | https://conductscience.org/library/papers/27192579 | PubMed |
| 11 | 33878161 | Cell engineering for the production of hybrid-type N-glycans in HEK293 cells. | J Biochem | 2021 | https://conductscience.org/library/papers/33878161 | PubMed |
| 12 | 12644702 | Rapid evolution of the neutralizing antibody response to HIV type 1 infection. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12644702 | PubMed |
| 13 | 12719580 | Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120. | J Virol | 2003 | https://conductscience.org/library/papers/12719580 | PubMed |
| 14 | 30326938 | The expanding array of HIV broadly neutralizing antibodies. | Retrovirology | 2018 | https://conductscience.org/library/papers/30326938 | PubMed |
| 15 | 32004464 | Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody. | Cell | 2020 | https://conductscience.org/library/papers/32004464 | PubMed |
| 16 | 20679402 | Human anti-HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness. | J Exp Med | 2010 | https://conductscience.org/library/papers/20679402 | PubMed |
| 17 | 25855300 | Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. | Nature | 2015 | https://conductscience.org/library/papers/25855300 | PubMed |
| 18 | 29718999 | Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/29718999 | PubMed |
| 19 | 27338952 | HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. | Nature | 2016 | https://conductscience.org/library/papers/27338952 | PubMed |
| 20 | 12019106 | Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12019106 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42774884 | Direct detection and quantification of HIV particles and their envelope trimers bound by combinations of broadly neutralizing antibodies. | iScience | 2026 | https://conductscience.org/library/papers/42774884 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38412036
GET https://conductscience.org/api/papers/v1/38412036/references?page=2